$36.74 (-0.730%)

Volume: 611.328k

Closed: Feb 03, 2023

Hollow Logo Score: 0.943
Arrowhead Research Corporation Stock
$36.74 (-0.730%)

Volume: 611.328k

Closed: Feb 03, 2023

Score Hollow Logo 0.943
NASDAQ:ARWR

Arrowhead Research Corporation Stock Price (Quote)

$36.74 ( -0.730% ) Friday, 3rd Feb 2023

Range Low Price High Price Comment
30 days $28.52 $38.96 Friday, 3rd Feb 2023 ARWR stock ended at $36.74. This is 0.73% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 4.09% from a day low at $36.23 to a day high of $37.71.
90 days $27.75 $41.03
52 weeks $26.81 $56.25

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2023-02-03 $36.36 $37.71 $36.23 $36.74 611 328
2023-02-02 $35.75 $37.01 $35.47 $37.01 726 080
2023-02-01 $34.85 $35.88 $34.27 $35.29 767 956
2023-01-31 $33.51 $35.03 $33.51 $34.99 854 449
2023-01-30 $33.20 $33.80 $32.89 $33.28 807 921
2023-01-27 $33.29 $34.08 $33.21 $33.61 427 156
2023-01-26 $33.24 $33.76 $32.60 $33.28 591 938
2023-01-25 $33.44 $33.82 $32.22 $32.97 756 175
2023-01-24 $32.53 $34.15 $32.23 $33.92 799 619
2023-01-23 $33.66 $33.69 $32.28 $32.70 1 232 614
2023-01-20 $34.48 $34.50 $33.14 $33.76 843 790
2023-01-19 $35.84 $36.13 $33.90 $33.93 907 829
2023-01-18 $37.11 $37.66 $35.64 $35.99 828 000
2023-01-17 $36.81 $37.67 $36.17 $36.91 937 663
2023-01-13 $35.99 $37.95 $35.62 $36.82 1 037 600
2023-01-12 $34.36 $36.17 $33.75 $36.15 938 300
2023-01-11 $33.07 $35.42 $32.47 $34.42 1 657 748
2023-01-10 $30.27 $33.05 $29.84 $33.03 1 850 057
2023-01-09 $30.05 $31.00 $28.52 $30.28 3 497 428
2023-01-06 $37.47 $38.32 $35.58 $37.38 946 000
2023-01-05 $37.50 $38.05 $36.77 $37.09 873 728
2023-01-04 $38.80 $38.96 $37.84 $38.08 1 074 366
2023-01-03 $40.80 $41.03 $36.96 $38.51 1 402 762
2022-12-30 $39.77 $40.62 $39.61 $40.56 787 669
2022-12-29 $38.08 $40.41 $37.59 $40.12 1 047 881
2022-12-28 $38.31 $38.98 $37.18 $37.56 563 198
2022-12-27 $38.51 $39.00 $37.90 $38.12 706 070
2022-12-23 $38.24 $38.78 $37.17 $38.30 776 668
2022-12-22 $36.64 $38.25 $36.34 $38.21 1 239 780
2022-12-21 $33.29 $37.24 $33.05 $37.10 1 719 784
2022-12-20 $31.00 $33.36 $30.98 $32.94 848 655
2022-12-19 $31.79 $31.99 $30.01 $31.07 815 726
2022-12-16 $31.00 $32.10 $30.86 $31.77 2 446 416
2022-12-15 $32.34 $32.58 $31.22 $31.44 665 006
2022-12-14 $32.79 $33.44 $32.35 $32.85 606 725
2022-12-13 $32.88 $33.52 $31.81 $32.85 782 258
2022-12-12 $30.39 $31.94 $30.12 $31.85 759 846
2022-12-09 $31.34 $31.35 $30.18 $30.24 771 350
2022-12-08 $33.14 $33.34 $31.38 $31.56 618 433
2022-12-07 $32.15 $33.06 $31.86 $32.86 647 765
2022-12-06 $31.74 $32.11 $31.32 $32.01 777 111
2022-12-05 $33.71 $33.71 $31.19 $31.82 888 081
2022-12-02 $31.97 $34.18 $31.37 $33.93 878 802
2022-12-01 $32.31 $33.29 $31.80 $32.02 772 669
2022-11-30 $30.62 $32.24 $30.03 $32.20 1 568 241
2022-11-29 $28.00 $31.70 $27.75 $29.99 1 775 843
2022-11-28 $29.30 $29.69 $28.00 $28.00 997 567
2022-11-25 $29.29 $29.81 $29.12 $29.50 507 121
2022-11-23 $29.55 $29.95 $29.07 $29.40 605 083
2022-11-22 $30.10 $30.10 $28.81 $29.55 1 091 342

Hot Stocks To Watch:

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT